Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic
The BeyeOMARKER study (Eudamed CIV ID: CIV-NL-23-09-044086; registration date: 19th of March 2024) is approved by the ethical review board of the Amsterdam UMC.
Authors
- Argonde C. van Harten (ORCID: https://orcid.org/0000-0002-1477-8724)
- Jurre den Haan (ORCID: https://orcid.org/0000-0003-1476-5568)
- Keir Yong (ORCID: https://orcid.org/0000-0002-9708-3599)
- Shannon R. Campbell
- Rik Ossenkoppele (ORCID: https://orcid.org/0000-0003-1584-7477)
- Ilse Bader
- Wiesje M. van der Flier (ORCID: https://orcid.org/0000-0001-8766-6224)
- Elsmarieke van de Giessen
- Femke H. Bouwman (ORCID: https://orcid.org/0000-0002-0527-2270)
- Colin Groot (ORCID: https://orcid.org/0000-0002-5802-6946)
- Frederik Barkhof (ORCID: https://orcid.org/0000-0003-3543-3706)
- Inge M.W. Verberk (ORCID: https://orcid.org/0000-0003-0341-7445)
- Charlotte Elisabeth Teunissen (ORCID: https://orcid.org/0000-0002-4061-0837)
- H. Stevie Tan (ORCID: https://orcid.org/0000-0001-8368-1048)
- Julie Antonelle Orellina
- David Wilson (ORCID: https://orcid.org/0000-0002-5198-7509)
- Yolande A.L. Pijnenburg (ORCID: https://orcid.org/0000-0003-2464-1905)
- Jean-Marie A. Milongo
- Pauline H. B. Kok
Institutions
- Lund University (SE)
- Bergman Clinics (NL)
- Amsterdam Neuroscience (NL)
- Quanterix (United States) (US)
- Optina Diagnostics (Canada) (CA)
- NIHR Queen Square Dementia Biomedical Research Unit (GB)
- Amsterdam University Medical Centers (NL)
- University College London (GB)
- Vrije Universiteit Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- Alzheimer s Research & Therapy
- Published
- 2024-08-21
- DOI
- https://doi.org/10.1186/s13195-024-01545-1
- Citations
- 7
- Primary Topic
- Retinal Imaging and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 2.83